NVO Novo Nordisk A/S

$55.45

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/22/2025

About Novo Nordisk A/S

Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.

Website: https://www.novonordisk.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
353278
Address
NOVO ALLE DK 2880, BAGSVAERD DENMARK, DK
Valuation
Market Cap
$285.37B
P/E Ratio
16.98
PEG Ratio
0.86
Price to Book
11.88
Performance
EPS
$3.42
Dividend Yield
2.78%
Profit Margin
34.80%
ROE
80.80%
Technicals
50D MA
$77.10
200D MA
$105.50
52W High
$145.26
52W Low
$57.28
Fundamentals
Shares Outstanding
3B
Target Price
$101.52
Beta
0.25

NVO EPS Estimates vs Actual

● Estimated
● Actual

NVO News & Sentiment

Aug 22, 2025 • Motley Fool NEUTRAL
Warren Buffett Makes a Big Buy
Berkshire Hathaway bought $1.6 billion of United Health stock in Q2. Inflation may be ticking higher after all.
Aug 22, 2025 • Benzinga NEUTRAL
Lost Money on Novo Nordisk A/S ( NVO ) ? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky - Novo Nordisk ( NYSE:NVO )
NEW YORK, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Novo Nordisk A/S ( "Novo" or the "Company" ) NVO of a class action securities lawsuit.
Aug 22, 2025 • Benzinga NEUTRAL
DEADLINE ALERT for HIMS, IRBT, CNC, BHVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - Biohaven ( NYSE:BHVN ) , Centene ( NYSE:CNC )
BENSALEM, Pa., Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Aug 22, 2025 • Benzinga NEUTRAL
MONDAY DEADLINE: Berger Montague Advises Hims & Hers Health Inc. ( NYSE: HIMS ) Investors to Inquire About a Securities Fraud Class Action by August 25, 2025 - Hims & Hers Health ( NYSE:HIMS )
PHILADELPHIA, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Berger Montague, a national securities litigation law firm, is investigating potential securities fraud claims against Hims & Hers Health Inc. ( "Hims & Hers" or the "Company" ) ( NYSE:HIMS ) .
Aug 22, 2025 • Benzinga NEUTRAL
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Novo To Contact Him Directly To Discuss Their Options
Aug 22, 2025 • Zacks Commentary NEUTRAL
Is Orforglipron Pill Setback End of the Road for LLY's Obesity Plans?
Lilly's obesity pill orforglipron disappointed with lower weight loss, but its broad late-stage pipeline keeps growth hopes alive.
Sentiment Snapshot

Average Sentiment Score:

0.105
50 articles with scored sentiment

Overall Sentiment:

Neutral

NVO Reported Earnings

Feb 05, 2025
Dec 31, 2024 (Pre market)
0.23 Surprise
  • Reported EPS: $6.34
  • Estimate: $6.12
  • Whisper: —
  • Surprise %: 3.7%
Nov 06, 2024
Sep 30, 2024 (Pre market)
0.02 Surprise
  • Reported EPS: $0.90
  • Estimate: $0.88
  • Whisper: —
  • Surprise %: 2.3%
Aug 07, 2024
Jun 30, 2024 (Pre market)
-0.08 Surprise
  • Reported EPS: $0.66
  • Estimate: $0.74
  • Whisper: —
  • Surprise %: -10.4%
May 02, 2024
Mar 31, 2024 (Pre market)
0.06 Surprise
  • Reported EPS: $0.83
  • Estimate: $0.77
  • Whisper: —
  • Surprise %: 7.8%
Jan 31, 2024
Dec 31, 2023 (Pre market)
0.05 Surprise
  • Reported EPS: $0.71
  • Estimate: $0.66
  • Whisper: —
  • Surprise %: 7.6%
Nov 02, 2023
Sep 30, 2023 (Pre market)
0.04 Surprise
  • Reported EPS: $0.73
  • Estimate: $0.69
  • Whisper: —
  • Surprise %: 5.8%
Aug 10, 2023
Jun 30, 2023 (Pre market)
0.04 Surprise
  • Reported EPS: $0.67
  • Estimate: $0.63
  • Whisper: —
  • Surprise %: 6.3%
May 04, 2023
Mar 31, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $0.63
  • Estimate: $0.61
  • Whisper: —
  • Surprise %: 3.3%
Feb 01, 2023
Dec 31, 2022 (Pre market)
-0.02 Surprise
  • Reported EPS: $0.41
  • Estimate: $0.43
  • Whisper: —
  • Surprise %: -5.3%

Financials